These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31082771)

  • 1. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
    Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
    Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
    [No Abstract]   [Full Text] [Related]  

  • 7. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-9-5p Exerts a Dual Role in Cervical Cancer and Targets Transcription Factor TWIST1.
    Babion I; Jaspers A; van Splunter AP; van der Hoorn IAE; Wilting SM; Steenbergen RDM
    Cells; 2019 Dec; 9(1):. PubMed ID: 31888045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
    Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
    Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation regulated microRNAs in human cervical cancer.
    Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
    Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer.
    Liu S; Song L; Yao H; Zhang L; Xu D; Li Q; Li Y
    Dis Markers; 2018; 2018():8949606. PubMed ID: 30344797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
    Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
    Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
    Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
    Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-22-3p and miR-30e-5p Are Associated with Prognosis in Cervical Squamous Cell Carcinoma.
    Kwon AY; Jeong JY; Park H; Hwang S; Kim G; Kang H; Heo JH; Lee HJ; Kim TH; An HJ
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.